ESC 365 - Ready for prime time as first-line therapy? PRO.

HFA Premium Access

Ready for prime time as first-line therapy? PRO.

Session: The Grand Debate 1: Neprilysin inhibitor - Vasodilators - LCZ 696 (Sacubitril/Valsartan)

Topic: Diuretics

Speaker: Professor J. McMurray (Glasgow, GB)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Professor John J V McMurray

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

127 presentations

26 followers

5 more presentations in this session

Ready for prime time as first-line therapy ? Introduction.

Speaker: Professor E. Braunwald (Boston, US)

Ready for prime time as first-line therapy ? CONTRA.

Speaker: Professor M. Jessup (Dallas, US)

Rebuttal - PRO.

Rebuttal - CONTRA.

Grand finale.

Access the full session

The Grand Debate 1: Neprilysin inhibitor - Vasodilators - LCZ 696 (Sacubitril/Valsartan)

Speakers: Professor J. McMurray, Professor E. Braunwald, Professor M. Jessup

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources